Defects in cardiac neural crest lead to congenital heart disease through failure of cardiac outflow tract and ventricular septation. In this report, we demonstrate a previously unappreciated role for the transcription factor Ets1 in the regulation of cardiac neural crest development. When bred onto a C57BL/6 genetic background, Ets1 -/-mice have a nearly complete perinatal lethality.
INTRODUCTION
The Ets family of transcription factors, of which there are now almost 30 members, are characterized by a winged helix-turn-helix DNA-binding domain termed the 'Ets' domain (Oikawa and Yamada, 2003) . Ets1, the founding member of the Ets transcription factor family, is widely expressed in the developing embryo, including the heart (Kola et al., 1993) . There is evidence to support a role for Ets1 during cardiovascular development in multiple animal model systems. Recent work in Ciona intestinalis has demonstrated that FGF signaling activates Ci-Ets1/2, the Ets1 homolog in Ciona, and directs cardiac lineage specification. Blockage of FGF signaling or inhibition of Ets1/2 leads to the failure of heart formation, whereas the ectopic activation of Ets1/2 expands the population of cells specified to the cardiac fate (Davidson et al., 2006) . In Drosophila, the Ets1 homolog pointed has been shown to regulate the cardioblast/pericardial cell fate decision. Flies that lack pointed generate an excess of cardioblasts at the expense of pericardial cell number in the posterior aspect of the developing heart tube (Alvarez et al., 2003) . Finally, in chick embryos, intravenous injection of a retrovirus encoding an antisense RNA directed against Ets1 and Ets2 resulted in embryos with a thin epicardium, disorganized coronary arteries and ventricular septal defects (Lie-Venema et al., 2003) . Taken together, these observations suggest the importance of Ets factors for the development of the cardiovascular system.
Given these results, we were interested in the role of Ets1 in mammalian heart morphogenesis. Ets1-deficient mice have been previously generated and have defects in natural killer (NK) cell, Tcell, and B-cell development, as well as in vascular inflammation and remodeling (Barton et al., 1998; Bories et al., 1995; Clements et al., 2006; Eyquem et al., 2004a; Eyquem et al., 2004b; Wang et al., 2005; Zhan et al., 2005) . In addition, a p51-isoform specific disruption of the murine Ets1 gene has also been generated and found to cause defects in lymphoid maturation (Higuchi et al., 2007) . Interestingly, in each of these reports, a perinatal lethality of Ets1-deficient mice was observed at variable penetrance. To date, however, this perinatal lethality has not been further characterized.
Given the evidence in other model organisms for the role of Ets1 in cardiovascular development, we hypothesized that the perinatal lethality observed in the Ets1-deficient mice was due to a defect in cardiac development. To investigate this possibility, we backcrossed Ets1-deficient mice for eight generations onto the C57BL/6 genetic background, making this perinatal lethality nearly completely penetrant. An analysis of these mice revealed cardiac malformations, including a membranous ventricular septal defect and a nodule of intra-cardiac cartilage. We show that cardiac neural crest fails to migrate appropriately and contribute to the membranous ventricular septum, suggesting a cause for the membranous ventricular septal defects seen in these mice. We also demonstrate that the intra-cardiac cartilage is derived from cells of the cardiac neural crest lineage and that the MEK/ERK signaling pathway upstream of Ets1 is required to block this cartilage formation. Together, these results suggest the importance of Ets1 in regulation of the migration and differentiation of a subset of the cardiac neural crest.
MATERIALS AND METHODS

Mouse strains
The previously described Ets1-deficient mice were backcrossed to C57BL/6 mice for eight generations (Barton et al., 1998) . Genomic DNA was prepared from the tails of mice or the yolk sac of embryos using a commercially available kit (Purgene, Qiagen, Valencia, CA, USA). Genotyping was performed using PCR and the primers 5Ј-GTCTTCTTCT CTA -GTTTCTGAGTGCTC, 5Ј-GTCCTGCTTACAACACTCTGAATCCTG and 5Ј-GCCTGCTCTTTACTGAAGGCTCTTT. Under these conditions, the wild-type allele will generate a 438-bp fragment and mutant allele a 350-bp fragment. /J], both on a C57BL/6 background, were obtained from Jackson Laboratories. Wnt1-Cre transgenic mice were obtained from Dr Akira Imamoto (University of Chicago, Chicago, IL, USA). All mice were cared for and experiments performed in accordance with the policies of the University of Chicago Animal Care and Use committee.
Histological analysis
Embryonic day (E) 18.5 embryos and newborn pups were sacrificed, skinned, fixed in 10% formalin at 4°C for 48 hours, dehydrated and then embedded in paraffin. Transverse sections (7 mm) were stained with Hematoxylin and Eosin for morphology. Similarly, embryos at E14.5-E18.5 were fixed, dehydrated and embedded in paraffin. Transverse sections were stained with Alcian Blue at pH 0.5 and counterstained with Neutral Red.
In situ hybridization
In situ hybridizations were performed on E10.5-E16.5 embryo sections as described previously (Flagg et al., 2007) . cDNA fragments specific to Ets1, Sox5, cartilage link protein (CLP; Hapln1 -Mouse Genome Informatics) and elastin were generated using RT-PCR and the following primers:
Ets1, 5Ј-GATATCCTGTGGGAGCATCTAGAGATC and 5Ј-CAGCT -GG ATCGGCCCACTTCCTGTGTAG;
Sox5, 5Ј-ATGGTGACAAGCAGACAGAAAGTG and 5Ј-GATC -TGCTCCTGTTGCTGCTTGG;
CLP, 5Ј-TGCAGTACCCAATCACCAAACC and 5Ј-TTCACGTA -ACTCAAGAACTGAC; and elastin, 5Ј-CTGGATCGCTGGCTGCATCC and 5Ј-CAGGGCT -CCAAGGGCTCCTC.
Fragments were cloned into the pGEM-T-Easy vector (Promega, Madison, WI, USA) and the resultant vectors were used to generate 35 Slabeled riboprobes. The Sox9 and Pax3 in situ hybridization probes have been previously described (Flagg et al., 2007; Milewski et al., 2004) .
b-galactosidase staining
Mouse embryos or hearts from newborn pups were harvested and incubated in b-galactosidase fix (0.2% glutaraldehyde, 5 mM EGTA, 100 mM MgCl 2 , and 100 mM sodium phosphate, pH 7.3) for 30 minutes at 4°C. Samples were then washed three times for 20 minutes each wash in wash buffer (0.01% sodium deoxycholate, 0.02% Nonidet-P40, 2 mM MgCl 2 , and 100 mM sodium phosphate, pH 7.3), followed by three washes in PBS. Subsequently, samples were incubated in 15% sucrose in PBS for 1 hour at 4°C, followed by overnight incubation in 30% sucrose in PBS. Samples were then embedded in OCT and 7 mm sections prepared using a Leica CM1850 cryostat. Sections were re-fixed in 0.2% glutaraldehyde in PBS for 10 minutes at 4°C, then washed three times for 5 minutes each wash in wash buffer. Sections were then incubated in bgalactosidase staining solution (1 mg/ml X-Gal, 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, 0.01% sodium deoxycholate, 0.02% Nonidet-P40, 2 mM MgCl 2 , and 100 mM sodium phosphate, pH 7.3) for 4 to 6 hours at 37°C. Following b-galactosidase staining, sections were washed three times with PBS and then counterstained with Nuclear Fast Red.
Immunofluorescence
Frozen sections were prepared from E12.5 mouse embryos and fixed for 30 minutes in 100% methanol. Sections were then washed with PBS and blocked in blocking buffer (PBS + 5% BSA + 0.2% Triton X-100) for 1 hour at room temperature. Sections were then incubated with a 1:100 dilution of a rabbit anti-Ets1 antibody (N-276, Santa Cruz Biotechnology) and a 1:200 dilution of a chicken anti-b-galactosidase antibody (ab3961, Abcam) for 2 hours at room temperature. Subsequently, sections were washed with PBS and incubated with a 1:500 dilution of an Alexa-488-conjugated goat antirabbit IgG antibody (A11008, Invitrogen, Carlsbad, CA, USA) and a 1:500 dilution of a Cy3-conjugated goat anti-chicken IgG antibody Jackson ImmunoResearch) . Sections were washed and immunofluorescence visualized with a Zeiss Axiophot fluorescence microscope.
Quantitative RT-PCR analysis
Total RNA from wild-type and Ets1 -/-newborn pup hearts were isolated using Trizol (Invitrogen) and first-strand cDNA was synthesized using Superscript reverse transcriptase (Invitrogen). Quantitative RT-PCR was performed using primers specific to:
Sox4, 5Ј-AGTGAAGCGCGTCTACCTGTTTGG and 5Ј-CATGCTCTCAAAGTTTGAGCTGGG;
Adam19, 5Ј-CTGGGGCTCGAATAGAAAGAAAGG and 5Ј-TATTG -CT CCAACCCTCTGTGATCG; Pdgfra, 5Ј-ACCTGAACCCAGACCATCG and 5Ј-CACGG AGG -AGGACAAAGACC; Sox5, 5Ј-ATGGTGACAAGCAGACAGAAAGTG and 5Ј-TTCCG -CCTTCTGAGGTGAGGTAG; Sox6, 5Ј-AACAGATCCAGCGGGAGCAACAAC and 5Ј-CTGGC -CGAGTGAGATCGATGACAC;
connexin 43 (Gja1 -Mouse Genome Informatics), 5Ј-TTCCTTTGACTTCAGCCTCCAAGG and 5Ј-AACCGGGTT GTT GA -GTGTTACAGC;
Gapdh, 5Ј-TGACAAGCTTCCCATTCTCG and 5Ј-GTGAAG GTC -GGTGTGAACG;
CLP, 5Ј-TGCAGTACCCAATCACCAAACC and 5Ј-CCACTTT -CGCGATCTGAGCACC; and aggrecan, 5Ј-GGAGCGAGTCCAACTCTTCAAGC and 5Ј-GCAGTA -CCACCTCCTTTTCCTTGG.
Primers for Meox1, Msx-2, Smad6, Snail, Notch1, Gata4, Gata6, FOG-2 (Zfpm2 -Mouse Genome Informatics), and Sox9 have been described previously (Flagg et al., 2007) . Data were analyzed and normalized to results obtained with primers specific to Gapdh (Tichopad et al., 2003) .
Whole heart organ culture
Whole heart organ culture was carried out as described previously (Lavine et al., 2006) . E13.5 mouse hearts were harvested and cultured in 5-ml glass scintillation vials containing 1 ml of DMEM supplemented with 10% FBS and 2 mg/ml heparin at 37°C, 5% CO 2 . The heart cultures were treated with DMSO or the MEK inhibitor U0126 (Calbiochem, San Diego, CA, USA) at a final concentration of 10 mm for 72 hours. Subsequently, the hearts were either fixed with 4% paraformaldehyde for Alcian Blue staining, used for western analysis, or used for quantitative RT-PCR analysis, as described above.
Western analysis
Fifty micrograms of whole heart lysate from hearts cultured in the absence or presence of U0126 were resolved by 10% SDS-PAGE and transferred to a nitrocellulose membrane (Whatman, Piscataway, NJ). The membrane was blocked with Blotto [10 mM Tris (pH 7.5), 140 mM NaCl, 0.05% Tween-20, and 5% instant milk] and then incubated with a 1:1000 dilution of a rabbit anti-phospho-Erk1/2 antibody (#9101, Cell Signaling Technology). The membrane was washed and incubated with a 1:5000 dilution of a HRPcoupled goat anti-rabbit IgG. The membrane was developed using autoradiography and a commercially available kit (ECL-plus, Amersham), and quantitated using Quantity One software. Subsequently, the membrane was stripped and re-probed with a 1:1000 dilution of an antibody directed against total Erk1/2 (#4695, Cell Signaling Technology).
RESULTS
Perinatal lethality of Ets1
-/-mice Two groups have previously generated Ets1-deficient mice and a third group has generated an isoform specific disruption of the Ets1 gene (Barton et al., 1998; Eyquem et al., 2004b; Higuchi et al., 2007) . In all three of these lines, a significant perinatal lethality was observed but not further characterized. To determine the cause of this lethality, we obtained Ets1 +/-mice originally generated by Barton et al. on a mixed genetic background and
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Development 137 (9) backcrossed this line to C57BL/6 mice for eight generations. We then intercrossed these Ets1 heterozygous mice and genotyped 99 offspring at weaning (Table 1) . We found a nearly complete absence of Ets1 -/-offspring at weaning with only one Ets1 -/-mouse identified, consistent with previous reports of a perinatal lethality. To determine the timing of lethality of the Ets1 -/-mice, we sacrificed and then genotyped embryos and neonatal pups of Ets1 heterozygous crosses. Embryos from E14.5 to E18.5 were present in nearly the expected Mendelian ratio ( Table 1 ). The genotypes of pups harvested on the day of birth also appeared to be in a nearly Mendelian ratio. However, by postnatal day 3, no Ets1 -/-pups were found in the 33 harvested, suggesting that nearly all of the Ets1-deficient mice were dying within the first 72 hours after birth.
Multiple cardiac defects in Ets1
-/-mice To investigate the cause of the perinatal lethality observed in the Ets1-deficient mice, we performed histological analysis on twelve E16.5 to postnatal day (P) 0 Ets1 -/-animals ( Fig. 1) . Eleven of the twelve animals examined showed a membranous ventricular septal defect, which was likely to contribute to the perinatal lethality (Fig.  1B) . Also, right ventricular dilation was noted in all the P0 animals examined. Other cardiac malformations were also present, but at incomplete penetrance, including an atrial septal defect (8/12), a muscular ventricular septal defect (6/12), dilated left and right atria (5/12), and a thin left ventricular wall (3/12) ( Table 2) . Finally, in all of the Ets1 -/-hearts examined (n=12), we observed an abnormal structure in the peri-aortic area, which had a histological appearance similar to cartilage (Fig. 1D ). Mason's trichrome and Alcian Blue staining of this structure supported the notion that this was indeed cartilage (Fig. 1E,F ). This structure was adjacent to the aorta at the level of the aortic valve, but was clearly outside of and distinct from the wall of the aorta. No direct continuity between the aortic valve leaflets and this abnormal focus of cartilage could be appreciated. We also observed a small nodule of peri-aortic cartilage in 50% of the heterozygous Ets1 hearts examined (n=4; see Fig. S1 in the supplementary material). To examine the development of the remainder of the skeleton of the Ets1 -/-embryos, we prepared Alcian Blue and Alizarin Red stained bone preparations from wildtype and Ets1 -/-newborn pups (see Fig. S2 in the supplementary material). We observed no significant difference in the ossification of the skull or the rest of the embryo.
To determine the time at which this nodule of cartilage formed in the hearts of Ets1 -/-mice, embryos from heterozygous intercrosses were harvested at E14.5 to E18.5, embedded, sectioned transversely, and stained with Alcian Blue (Fig. 2) . The results reveal that this focus of cartilage first developed between E14.5 and E16.5 in Ets1 -/-mice, a period in mouse embryonic development in which significant maturation of the endocardial cushions and the interventricular septum is occurring.
Expression of Ets1 in developing endocardial cushions of the mouse heart
As a first step towards understanding the molecular pathways perturbed in the Ets1-deficient mice, we sought to further define the pattern of expression of Ets1 in the heart during cardiac development. Although previous reports demonstrated via northern analysis that Ets1 is expressed in the developing mouse heart (Maroulakou et al., 1994) , the temporal and cell-type-specific pattern of expression was not examined. Work in chick embryos suggested Ets1 is initially expressed in the endocardium and epicardium at Hamburger and Hamilton stage 16, with increased expression in areas of endothelial-to-mesenchymal transformation in the endocardium, the epicardium and the subepicardial matrix by stage 33 (Macias et al., 1998) . To examine the pattern of expression of Ets1 in mouse embryos during these stages of heart development, we performed in situ hybridization using an Ets1-specific probe on sections of mouse embryos from E10.5 to E14.5 (Fig. 3) . Consistent with observations in the chick heart, Ets1 expression in the murine heart was detected in the developing endocardial cushions of the Ets1 +/-mice were crossed and E14.5-E18.5 embryos (embryonic), animals at birth (P0), at the third day after birth (P3), or at weaning (P21) were genotyped by PCR. -/-mice (B, arrow). In C-F, transverse sections at the level of the aortic valve leaflets reveal an abnormal structure in the aortic area in Ets1 -/-mice (arrows). Ao, aorta; LV, left ventricle; RV, right ventricle. outflow tract at E10.5 (Fig. 3D) , a time at which the migration of cardiac neural crest into the outflow tract endocardial cushions has begun. At E12.5, high-level expression of Ets1 was localized to the epicardium and to the endocardium overlying the endocardial cushions (Fig. 3E, arrow) . Notably, Ets1 expression was not detected in the myocardium at this time in development. At E14.5, a similar expression pattern was observed. Of note, Ets1 was highly expressed at the junctions between the endocardial cushions that fuse to form the membranous interventricular septum (Fig. 3F, arrow) . Given that cells derived from the cardiac neural crest are known to contribute to the endocardial cushions during early cardiac development (Stoller and Epstein, 2005) , we wanted to determine whether Ets1 was expressed in this cell population. To address this question, we performed immunofluorescence using antibodies specific to b-galactosidase and Ets1 on sections of outflow tract endocardial cushions from E12.5 ROSA-26R lacZ ; Wnt1-Cre + transgenic embryos. In these embryos, cells derived from the neural crest lineage are genetically marked by b-galactosidase expression . Consistent with our in situ hybridization data shown in Fig. 3E , immunofluorescence using an anti-Ets1 antibody revealed expression in the endocardium overlying the endocardial cushions (Fig. 3G) . In addition, a fraction of mesenchymal cells within the cushion were also positive for Ets1 expression and these cells also expressed b-galactosidase (Fig. 3H,I ), demonstrating their neural crest origin. Taken together, these results establish that Ets1 is expressed in the endocardium and in neural crest-derived cells of the endocardial cushions at the precise time in development at which to play a role in the maturation of the outflow tract and the membranous ventricular septum.
Sox9, aggrecan and CLP are upregulated in Ets1-deficient hearts
As an approach towards understanding the molecular basis for the morphological defects seen in the hearts of the Ets1 -/-mice, we used quantitative RT-PCR to screen candidate genes for altered levels of expression (Table 3) . We chose genes known to be important regulators of endothelial-to-mesenchymal transformation during endocardial cushion development (Meox1, Msx2, Smad6, Snail, Gata4) , genes known to regulate neural crest whose deficiency leads to ventricular septal defects (Sox4, Adam19, Gata6, Pdgfra), or genes known to be involved in cartilage development (Sox9, Sox5, Sox6, CLP, aggrecan) (Komatsu et al., 2007; Morrison-Graham et al., 1992; Schilham et al., 1996; Tullio et al., 1997; Ya et al., 1998) . In Ets1 -/-hearts, we found no difference in expression of genes involved in the regulation of endothelial-to-mesenchymal transformation, but did observe that genes involved in the migration and differentiation of cardiac neural crest (i.e. Gata6 and Sox4) were modestly, yet significantly, downregulated. However, Pax3, a crucial marker of the neural crest, was still highly expressed in the neural tube of E12.5 Ets1 -/-embryos (see Fig. S3 in the supplementary material). We also found statistically significant increases in CLP, aggrecan, and Sox9, a transcription factor that is crucial for the formation of chondrocytes (Akiyama et al., 2005) . Because our histological analysis of the Ets1-deficient mice suggested the presence of an abnormal focus of cartilage in the periaortic region within the heart, we hypothesized that this increase in Sox9, aggrecan and CLP expression was due to local, high-level expression within this area. To confirm this, we performed in situ hybridization using probes specific to Sox9 and CLP on sections of E16.5 hearts (Fig. 4) . Sox9 was expressed in a similar fashion in the lung and bronchial cartilage in both wild-type and Ets1
-/-mice (data RESEARCH ARTICLE Development 137 (9) not shown). However, we also found high-level expression of Sox9 in the focus of aberrant cartilage in Ets1 -/-hearts. Expression of CLP gave a similar pattern (Fig. 4F, arrowhead) . We also examined the expression of Sox5, another crucial transcriptional regulator in chondrocytes. As with Sox9 and CLP, Sox5 was also expressed in this structure (Fig. 4D, arrowhead) . Finally, we examined the expression of elastin, a gene that is highly expressed in the wall of the aorta and in the developing heart valves. We found that this abnormal peri-aortic structure did not express elastin (Fig. 4H,  arrowhead) . Together with the histological analysis shown in Fig. 1 , these results confirm that this aberrant tissue within the peri-aortic region of the heart is indeed cartilage. Furthermore, this tissue appears to be distinct from that of the wall of the aorta and the aortic valve, given its lack of elastin expression.
Cells of the neural crest lineage give rise to the abnormal focus of intra-cardiac cartilage
In order to gain further insight into the mechanism leading to the formation of the intra-cardiac cartilage observed in the Ets1 -/-mice, we next sought to determine the cellular origin of this cartilage. As the outflow tract endocardial cushions contain cells derived from both the endocardium, through endocardial-to-mesenchymal transformation (EMT), and the cardiac neural crest, we undertook lineage-tracing experiments using genetic markers of either the endocardium or cardiac neural crest lineages. In our first series of experiments, we used transgenic expression of Cre recombinase driven by the Tie2 promoter (Tie2-Cre) to mark cells derived from the endocardium. We bred Ets1 +/-mice with the Cre reporter line ROSA-26R lacZ to generate Ets1 +/-; ROSA-26R lacZ/lacZ mice. These mice were then crossed with Ets1 +/-; Tie2-Cre + to yield Ets1 -/-; ROSA-26R lacZ ; Tie2-Cre + pups. These pups were harvested at birth, their hearts sectioned and then stained for b-galactosidase expression (Fig. 5) . In these sections, cells that are derived from the endocardium or endothelial cells will stain blue. As expected, the endocardium and many of the cells within the developing valve stained positively for b-galactosidase expression. However, the abnormal focus of peri-aortic cartilage did not, demonstrating that these cells are not derived from the endocardium through endothelial-to-mesenchymal transformation (Fig. 5B, arrow) . To assess whether this focus of cartilage is derived from the cardiac neural crest, we used transgenic expression of Cre recombinase driven by the Wnt1 promoter (Wnt1-Cre) to mark cells derived from the neural crest. We crossed the Ets1 ; Wnt1-Cre + pups. When hearts from these mice were stained for bgalactosidase expression, we observed blue cells within the wall of the aorta, as well as in the peri-aortic mesenchyme. Importantly, all of the cells in the ectopic focus of cartilage were blue (Fig. 5D , arrow), indicating that this cartilage was derived from cells of the neural crest lineage.
Neural crest migration defects in Ets1
-/-mice Neural crest cells are known to migrate into both the distal and proximal regions of the outflow tract endocardial cushions Waldo et al., 1998) , where they are thought to direct the fusion of the opposing endocardial cushions in the outflow tract. Failure of fusion of the conal endocardial cushions with the superior atrioventricular cushion will result in a membranous ventricular septal defect. Failure of complete migration of the cardiac neural crest has been described in mice with a neural crest-specific deletion of Gata6 (Lepore et al., 2006) , a gene that is significantly downregulated in the Ets1 -/-mice (Table 3) . Thus, we hypothesized that neural crest migration might be perturbed in Ets1 -/-mice, resulting in a ventricular septal defect. Our first indication that neural crest cells might be perturbed was provided 1547 RESEARCH ARTICLE Ets1 and the cardiac neural crest by visual inspection of our only Ets1 -/-mouse to survive to adulthood (Fig. 6A) . In addition to this mouse being growth retarded, it also had a large patch of white fur on its ventral aspect, reminiscent of the pigmentation defects seen in splotch mice (Epstein et al., 2000) . In addition, a careful inspection of Ets1 heterozygotes revealed that they were slightly smaller than their wild-type littermates (see Fig. S1B ,C in the supplementary material) and that approximately 60% of them also had a small ventral pigmentation defect. As the pigmentation defects seen in the splotch mice are known to be due to defects in the neural crest, this observation suggested that the neural crest in Ets1 -/-mice might be perturbed.
To examine the migration of cardiac neural crest cells in the Ets1-deficient mice, we harvested Ets1 -/-; ROSA-26R lacZ ; Wnt1-Cre + embryos at E13 and stained sections of both the distal and proximal outflow tract of these embryos for b-galactosidase expression to highlight cells of neural crest origin ( Fig. 6B-E) . As the transcription factor Sox10 is also known to mark cells of the neural crest lineage (Hong and Saint-Jeannet, 2005) , immunofluorescence using antibodies to Sox10 further confirmed that these b-galactosidasepositive cells were of neural crest origin (see Fig. S4 in the supplementary material). Consistent with previous reports, we observed cardiac neural crest cells in wild-type embryos in the distal and proximal portions of the outflow tract endocardial cushions (Fig.  6B,D, arrows) . In the Ets1 -/-hearts, cells of the cardiac neural crest lineage were present in the distal portion of the outflow tract (Fig.  6C) , although there appeared to be less cells of the cardiac neural crest contributing to the aortic valve leaflets. In the proximal outflow tract, where the conal endocardial cushions, the muscular ventricular septum and the superior atrioventricular cushion converge, there was a complete absence of cardiac neural crest cells in the Ets1 -/-heart (Fig. 6E) , suggesting that their migration to this region was disrupted.
Inhibition of MEK activity results in cardiac cartilage formation
As a final step in our characterization of the aberrant cartilage found in Ets1-deficient hearts, we sought to place Ets1 within the molecular pathways regulating chondrocyte differentiation. Sox9 is a crucial regulator of this process (Kawamura and Urist, 1988) , whereas FGF signaling through the MEK/ERK pathway has been shown to inhibit cartilage formation (Bobick and Kulyk, 2004) . It is also well established that ERK can directly phosphorylate Ets1 and increase its transcriptional activity on target promoters (Brent and Tabin, 2004) . Therefore, we speculated that MEK and ERK might function upstream of Ets1 to block cartilage formation during the differentiation of neural crest within the endocardial cushions. If this were the case, inhibiting MEK activity within the developing heart would lead to the loss of activated Ets1 and the formation of aberrant cartilage, similar to that seen in Ets1-deficient mice. To test this notion, we harvested wild-type E13.5 hearts and cultured them in the absence or presence of the MEK inhibitor U0126 for 72 hours. Western analysis of heart lysates revealed that ERK phosphorylation was blocked 85.5±2.5% by treatment with U0126 (Fig. 7A) . A second preparation of cultured hearts was fixed, sectioned, and stained for cartilage using Alcian Blue. As seen in Fig. 7B , hearts treated with vehicle alone showed no evidence for cartilage formation, whereas hearts cultured in the presence of U0126 developed a focus of Alcian Blue-positive staining near the aorta, indicative of cartilage formation (n=3/3). Quantitative RT-PCR was performed on similarly cultured hearts and demonstrated a 56±4% induction of Sox9 expression (P=0.006) and a 2.9±0.4-fold induction of aggrecan (P=0.005, Fig. 7C ), further supporting the observation that cartilage forms in these MEK-inhibited hearts.
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DISCUSSION
In this report, we describe the cardiac defects present in Ets1-deficient mice. These mice have an abnormal focus of peri-aortic cartilage derived from cells of the cardiac neural crest. In addition, they have a membranous ventricular septal defect due to the failure of fusion of the outflow tract cushions below the level of the semilunar valves, which is likely to be secondary to a subtle migration defect of the cardiac neural crest. The ventricular septal defect probably contributed to the death of the Ets1 -/-pups shortly after birth. As has been reported for other mouse models of congenital heart disease, the penetrance of this phenotype is dependent on the genetic background of the mice. On a mixed 129/SVJ and C57BL/6 background, the incidence of perinatal lethality was less than 50%, but on a nearly pure C57BL/6 background, the penetrance of this perinatal lethality approached 100%. This observation suggests the presence of a modifier gene(s) present in the 129SVJ background that can compensate for the loss of Ets1 and allow the animals to survive to adulthood.
The defects seen in Ets1-deficient mice are similar to some of the cardiac developmental abnormalities observed in chick embryos in which both Ets1 and Ets2 expression was reduced using a retroviral-mediated antisense strategy (Lie-Venema et al., 2003) . In these treated chick embryos, 25% had sub-aortic ventricular septal defects similar those described in this report. The lower incidence of these septal defects in the chick system as compared with our results might be due to the difficulty in achieving complete loss of Ets expression in vivo using an antisense strategy. The presence of an ectopic focus of cartilage was also not reported in this system, perhaps because the chick embryos did not survive long enough to allow the development of the cartilage in the peri-aortic region.
Targeted disruption of many different genes in mice has resulted in mutants with ventricular septal defects. Some of these genes appear to function in cardiomyocytes to promote the development of the endocardial cushion tissue (e.g. Hey2, Myh10), whereas others are expressed specifically within cells of the endocardial cushions (Sakata et al., 2002; Tullio et al., 1997) . Genes expressed within the endocardial cushions can affect endothelial-to-mesenchymal transformation (e.g. Sox9, Nf1, Gata4), while others affect the function of the cardiac neural crest (e.g. Pax3, Adam19 or Gata6) (Akiyama et al., 2004; Epstein et al., 2000; Gitler et al., 2003; Komatsu et al., 2007; Lepore et al., 2006; Rivera-Feliciano et al., 2006) . In order to properly remodel the outflow tract, neural crest cells must first migrate to the correct positions within the conotruncal cushions (Waldo et al., 1998) . The neural crest cells within the most proximal part of the conal cushions are believed to direct the fusion of this cushion with the superior atrioventricular cushion. Failure of fusion leads to a membranous ventricular septal defect, as seen in the Ets1-deficient mice. This fusion failure is similar to that observed in Adam19-deficient mice (Komatsu et al., 2007) . However, in those embryos, the neural crest migrated to the correct position within the conal cushions, but failed to promote fusion. In the Ets1 -/-mice, the neural crest cells failed to complete migration to the most proximal aspect of the cushions and were therefore unable to direct cushion fusion. The fur pigmentation defect observed in the Ets1 -/-mice ( Fig. 6A ) is also consistent with a defect in neural crest cell migration, as melanocytes are also derived from migratory cells of the neural crest lineage (Crane and Trainor, 2006) . Importantly, the remodeling of the rest of the outflow tract occurred normally in Ets1-deficient mice, consistent with our observation that the neural crest cells were present in the distal outflow tract to direct this remodeling.
What was the fate of the neural crest cells that failed to migrate to the proximal outflow tract endocardial cushions? We propose that these neural crest cells differentiated into the nodule of cartilage seen in the peri-aortic area of the Ets1 -/-mice. The results of our lineagetracing experiments shown in Fig. 6 demonstrate that this cartilage nodule is derived from neural crest. Therefore, we feel it is plausible that these chondrocytes are derived from those neural crest cells that should have migrated to the developing interventricular septum and directed fusion of the endocardial cushions during the later stages of heart development. However, we cannot rule out the possibility that the neural crest cells that formed the cartilage nodule in the Ets1 -/-mice were derived from a population of neural crest not destined for the membraneous ventricular septum.
It is clear that normal neural crest cells have the potential to differentiate into chondrocytes, as shown during jaw development and by chick-quail chimera studies (Chai et al., 2000; Kirby, 1989) . The results reported here suggest that Ets1 functions to block the differentiation of cardiac neural crest into cartilage. Consistent with this notion, Ets1 has been previously shown not to be expressed in cartilage (Dhordain et al., 1995) . Moreover, we would also suggest that MEK and ERK are directly upstream of Ets1 in this pathway, given that Ets1 is a known target of ERK-mediated signaling and that the MEK/ERK pathway is a negative regulator of chondrocyte differentiation (Bobick and Kulyk, 2004; Paumelle et al., 2002; Yang et al., 1996) . This hypothesis is supported by our results showing the formation of cartilage within hearts treated with the MEK inhibitor U0126 (Fig. 7) . Taken together, these observations suggest a molecular pathway of MEK, ERK and Ets1 that blocks the development of chondrocytes from cells of the neural crest lineage (Fig. 7D) .
Interestingly, an intra-cardiac focus of cartilage has also been reported in transgenic mice expressing a dominant-negative form of Cx43 (Sullivan et al., 1998) . Similar to the cartilage seen in the Ets1 -/-mice, the cartilage seen in these mice was localized near to the semilunar valves and was suggested to be due to the disruption of Cx43 function in the cardiac neural crest. Moreover, Cx43 has also been shown to activate the MEK/ERK pathway (Plotkin et al., 2002; Stains and Civitelli, 2005) . Thus, it is possible that in the neural crest, Cx43 signals to Ets1 via the MEK/ERK pathway to block the formation of chondrocytes during the neural crest-directed remodeling of the cardiac outflow tract. However, other activators of MEK might also be important in the activation of this pathway.
Finally, although we and others have demonstrated that Ets1 is expressed in neural crest (Kola et al., 1993) , it is also expressed in other cell types within the developing heart (see Fig. 3 ). Given this, we cannot currently distinguish whether Ets1 plays a cell autonomous or a non-cell autonomous role in regulating the migration and/or differentiation of the cardiac neural crest. The answer to this question must await the generation of a mouse line with the Ets1 gene specifically ablated in cells of the neural crest.
